These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10488811)

  • 1. Coagulation activation in patients with Binswanger disease.
    Tomimoto H; Akiguchi I; Wakita H; Osaki A; Hayashi M; Yamamoto Y
    Arch Neurol; 1999 Sep; 56(9):1104-8. PubMed ID: 10488811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coagulation-fibrinolysis system in patients with leukoaraiosis and Binswanger disease.
    Tomimoto H; Akiguchi I; Ohtani R; Yagi H; Kanda M; Shibasaki H; Yamamoto Y
    Arch Neurol; 2001 Oct; 58(10):1620-5. PubMed ID: 11594920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.
    Gando S; Nanzaki S; Sasaki S; Aoi K; Kemmotsu O
    Crit Care Med; 1998 Dec; 26(12):2005-9. PubMed ID: 9875912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance.
    Catena C; Zingaro L; Casaccio D; Sechi LA
    Am J Med; 2000 Nov; 109(7):556-61. PubMed ID: 11063957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation system activated in Duchenne muscular dystrophy patients with cardiac dysfunction.
    Saito T; Yamamoto Y; Matsumura T; Nozaki S; Fujimura H; Shinno S
    Brain Dev; 2005 Sep; 27(6):415-8. PubMed ID: 16122628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
    Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis abnormalities in familial amyloid polyneuropathy.
    Takahashi R; Ono K; Ikeda T; Akagi A; Noto D; Nozaki I; Sakai K; Asakura H; Iwasa K; Yamada M
    Amyloid; 2012 Sep; 19(3):129-32. PubMed ID: 22624582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
    Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
    Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
    van Wersch JW; van Mourik-Alderliesten CH; Coremans A
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation and fibrinolysis activation after single-incision versus standard laparoscopic cholecystectomy: a single-center prospective case-controlled pilot study.
    Zezos P; Christoforidou A; Kouklakis G; Tsalikidis C; Dimakis C; Laftsidis P; Virgiliou A; Simopoulos C; Pitiakoudis M
    Surg Innov; 2014 Feb; 21(1):22-31. PubMed ID: 23575915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
    Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
    Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
    Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
    Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
    Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
    Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.